Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis

Abstract Background Retinol binding protein 4 (RBP4) is implicated in obesity, insulin resistance and type 2 diabetes mellitus that are closely associated with nonalcoholic fatty liver disease (NAFLD). However, recent investigations regarding circulating RBP4 levels in NAFLD are conflicting. This me...

Full description

Bibliographic Details
Main Authors: Zhongwei Zhou, Hongmei Chen, Huixiang Ju, Mingzhong Sun
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12944-017-0566-7
id doaj-ed600592f8ac4d3086eb30f41881bed0
record_format Article
spelling doaj-ed600592f8ac4d3086eb30f41881bed02020-11-25T00:50:51ZengBMCLipids in Health and Disease1476-511X2017-09-011611810.1186/s12944-017-0566-7Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysisZhongwei Zhou0Hongmei Chen1Huixiang Ju2Mingzhong Sun3Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast UniversityDepartment of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast UniversityDepartment of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast UniversityDepartment of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast UniversityAbstract Background Retinol binding protein 4 (RBP4) is implicated in obesity, insulin resistance and type 2 diabetes mellitus that are closely associated with nonalcoholic fatty liver disease (NAFLD). However, recent investigations regarding circulating RBP4 levels in NAFLD are conflicting. This meta-analysis is to determine whether NAFLD, non-alcoholic steatohepatitis (NASH) and simple steatosis (SS) patients have altered RBP4 levels. Methods We performed a systematic search in PubMed, EMBASE and The Cochrane Library up until 18 March 2017, and 12 studies comprising a total of 4247 participants (2271 NAFLD patients and 1976 controls) were included in the meta-analysis. Results There were no significant differences of circulating RBP4 levels in the following comparisons: (1) NAFLD patients vs controls (standardized mean differences [SMD]: 0.08; 95% CI: −0.21, 0.38); (2) NASH patients vs controls (SMD: −0.49; 95% CI: −1.09, 0.12); (3) SS patients vs controls (SMD: −0.72; 95% CI: −1.64, 0.20) and (4) NASH vs SS patients (SMD: −0.04; 95% CI: −0.32, 0.24). The results remained essentially unchanged in the comparisons between NAFLD patients and controls after excluding single individual study or bariatric studies (n = 2). No significant publication bias was detected. However, there was significant heterogeneity among studies and the subgroup and meta-regression analyses did not find the potential sources. Conclusions Circulating RBP4 levels may not be associated with NAFLD. Further prospective cohort studies are required to confirm these findings.http://link.springer.com/article/10.1186/s12944-017-0566-7Retinol binding protein 4Nonalcoholic fatty liver diseaseNon-alcoholic steatohepatitisSimple steatosisMeta-analysis
collection DOAJ
language English
format Article
sources DOAJ
author Zhongwei Zhou
Hongmei Chen
Huixiang Ju
Mingzhong Sun
spellingShingle Zhongwei Zhou
Hongmei Chen
Huixiang Ju
Mingzhong Sun
Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Lipids in Health and Disease
Retinol binding protein 4
Nonalcoholic fatty liver disease
Non-alcoholic steatohepatitis
Simple steatosis
Meta-analysis
author_facet Zhongwei Zhou
Hongmei Chen
Huixiang Ju
Mingzhong Sun
author_sort Zhongwei Zhou
title Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
title_short Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
title_full Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
title_fullStr Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
title_full_unstemmed Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
title_sort circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
publisher BMC
series Lipids in Health and Disease
issn 1476-511X
publishDate 2017-09-01
description Abstract Background Retinol binding protein 4 (RBP4) is implicated in obesity, insulin resistance and type 2 diabetes mellitus that are closely associated with nonalcoholic fatty liver disease (NAFLD). However, recent investigations regarding circulating RBP4 levels in NAFLD are conflicting. This meta-analysis is to determine whether NAFLD, non-alcoholic steatohepatitis (NASH) and simple steatosis (SS) patients have altered RBP4 levels. Methods We performed a systematic search in PubMed, EMBASE and The Cochrane Library up until 18 March 2017, and 12 studies comprising a total of 4247 participants (2271 NAFLD patients and 1976 controls) were included in the meta-analysis. Results There were no significant differences of circulating RBP4 levels in the following comparisons: (1) NAFLD patients vs controls (standardized mean differences [SMD]: 0.08; 95% CI: −0.21, 0.38); (2) NASH patients vs controls (SMD: −0.49; 95% CI: −1.09, 0.12); (3) SS patients vs controls (SMD: −0.72; 95% CI: −1.64, 0.20) and (4) NASH vs SS patients (SMD: −0.04; 95% CI: −0.32, 0.24). The results remained essentially unchanged in the comparisons between NAFLD patients and controls after excluding single individual study or bariatric studies (n = 2). No significant publication bias was detected. However, there was significant heterogeneity among studies and the subgroup and meta-regression analyses did not find the potential sources. Conclusions Circulating RBP4 levels may not be associated with NAFLD. Further prospective cohort studies are required to confirm these findings.
topic Retinol binding protein 4
Nonalcoholic fatty liver disease
Non-alcoholic steatohepatitis
Simple steatosis
Meta-analysis
url http://link.springer.com/article/10.1186/s12944-017-0566-7
work_keys_str_mv AT zhongweizhou circulatingretinolbindingprotein4levelsinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis
AT hongmeichen circulatingretinolbindingprotein4levelsinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis
AT huixiangju circulatingretinolbindingprotein4levelsinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis
AT mingzhongsun circulatingretinolbindingprotein4levelsinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis
_version_ 1725246152931016704